YLT-11 | Interleukin Related interleukin-related.com

Product Name :
YLT-11

Search keywords :
YLT-11

drugId :
null

Target Vo:
Polo like kinase 4

Target Vo Short Name :
PLK4

Moa_Name:

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sichuan University

Active Company_Name :
Sichuan University

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
eIF4EBP1 Rabbit mAb manufacturer
Actoxumab Purity & Documentation
Glu-Glu Tag Antibody: Glu-Glu Tag Antibody is a non-conjugated and Mouse origined monoclonal antibody, targeting to Glu-Glu Tag. It can be used for WB assays with Glu-Glu-tag, in the background of Species independent.

Author: Interleukin Related

Related Posts